At $60 per share, Bio-Techne trades at 29.1x forward P/E. Dive into our free research report to see why there are better opportunities than TECH . 5 Hot Stocks to Buy Now: October's Top Picks With Major Upside BIIB stock price recently tested the $230 psychological resistance after rallying on supportive biotech sector flows. Traders remain focused on upcoming FDA decision timelines that could serve as strong volatility catalysts for the next quarter. Analysts forecast possible 5–8% upside if approvals align with expectations.
